Hainan

605199.SS

Tags: CN Healthcare Biotechnology

Hainan Huluwa Pharmaceutical Group Co., Ltd. Price (605199.SS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

394,436,231

(1.4177)%

Market Cap of Hainan (605199.SS)

Market cap:

As of , 605199.SS has a market cap of . This makes 605199.SS the 1900th most valuable company in the CN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Hainan Huluwa Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of drugs in the areas of Children's respiratory and digestive systems in China. Its primary products include 4 grams of pediatric lung heat cough granules and capsules. The company was founded in 2005 and is based in Haikou, China. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $9.09-25.16
Market Cap 6.75B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Ms. Jinping Liu
IPO Date: July, 10, 2020
Country: CN
Currency: CNY
Headquaters: No Data
Employees: 2468

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: